Skip to main content

Table 2 Percent of Ideal Dose (mean ± SD)

From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study

Course

# of Patients

% Methotrexate

% Leucovorin

% 5-FU

1

94

98.9 ± 7.2

99.9 ± 0.7

98.8 ± 10.3

5

76

90.1 ± 18.9

91.8 ± 17.4

86.3 ± 24.4

10

48

88.6 ± 19.9

87.8 ± 20.2

84.7 ± 44.2

15

34

90.3 ± 19.8

93.5 ± 16.4

89.0 ± 19.7

20

25

83.0 ± 24.2

89.7 ± 19.3

84.3 ± 22.9

25

15

76.7 ± 28.2

80.7 ± 26.7

77.2 ± 28.7

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us